Appendices
Pfizer Inc.
Income Statements for the years ending 31 December,
Figures in $ millions except earnings per share
Revenue
Cost of sales
Gross profit
Selling, and administration expenses
Research and development
Amortisation of intangible assets
Restructuring and certain acquisition costs
Other income/(deductions)
Profit from continuing operations before taxes
Taxation
Profit from continuing operations after taxes
Discontinued operations (net of tax):
Profit from discontinued operations
Gain on disposal of discontinued operations
Discontinued operations
Total profit for the year
Profit allocated to non-controlling interests
Profit attributable to Pfizer Inc.
6
(55)
(49)
9,071
32
9,039
308
10,354
10,662
22,072
69
22,003
794
4,783
5,577
14,598
28
14,570
Earnings per Share
Basic earnings per share
Diluted earnings per share
Source: Pfizer annual reports for years 2012, 2013 and 2014
1.44
1.42
3.23
3.19
1.96
1.94
2014
2013
2012
2014
Turnover
Cost of sales
Gross profit
Royalty income
2013
2012
310
387
306
(700)
1,124
1,256
Operating profit
3,597
7,028
7,300
68
61
79
(727)
(767)
(808)
282
30
43
29
2,968
6,647
6,600
Taxation
2,831
5,628
4,678
75
192
179
2,756
5,436
4,499
Finance income
Finance expenses
Profit on disposal of interest in associates
Share of profit from associates and joint ventures
57.3
112.5
110.5
91.6
90.2
2012
8,776
4,359
10,161
579
787
2,391
54
682
27,789
3,969
103
5,242
49
81
4,184
64
13,692
41,481
1,349
2,022
642
1,787
5,800
937
6,737
14,671
1,004
3,121
701
1,432
20,929
3,631
8,054
63
1,374
693
13,815
41,481